# C_2017058EN.01001001.xml

| 23.2.2017 | EN | Official Journal of the European Union | C 58/10 |
| --- | --- | --- | --- |

23.2.2017

EN

Official Journal of the European Union

C 58/10

---

Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the first half of 2016

(2017/C 58/08)

Subcommittee I on the free movement of goods

Subcommittee I on the free movement of goods

To be noted by the EEA Joint Committee

To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 January-30 June 2016, at their meeting on 28 October 2016:

| Annex I | List of new marketing authorisations |
| --- | --- |
| Annex II | List of renewed marketing authorisations |
| Annex III | List of extended marketing authorisations |
| Annex IV | List of withdrawn marketing authorisations |
| Annex V | List of suspended marketing authorisations |

Annex I

Annex I

List of new marketing authorisations

Annex II

Annex II

List of renewed marketing authorisations

Annex III

Annex III

List of extended marketing authorisations

Annex IV

Annex IV

List of withdrawn marketing authorisations

Annex V

Annex V

List of suspended marketing authorisations

---

ANNEX I

List of new marketing authorisations

The following marketing authorisations have been granted in the EEA EFTA States during the period 1 January-30 June 2016:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/15/1053 | Neofordex | Liechtenstein | 30.4.2016 |
| EU/1/15/1053 | Neofordex | Iceland | 31.3.2016 |
| EU/1/15/1053 | Neofordex | Norway | 1.4.2016 |
| EU/1/15/1063 | Pemetrexed Actavis | Liechtenstein | 29.2.2016 |
| EU/1/15/1063 | Pemetrexed Actavis | Norway | 25.1.2016 |
| EU/1/15/1063 | Pemetrexed Actavis | Iceland | 25.1.2016 |
| EU/1/15/1064 | Imlygic | Liechtenstein | 29.2.2016 |
| EU/1/15/1064 | Imlygic | Norway | 20.1.2016 |
| EU/1/15/1064 | Imlygic | Iceland | 14.1.2016 |
| EU/1/15/1065 | Eptifibatid Accord | Liechtenstein | 29.2.2016 |
| EU/1/15/1065 | Eptifibatide Accord | Norway | 18.1.2016 |
| EU/1/15/1065 | Eptifibatide Accord | Iceland | 14.1.2016 |
| EU/1/15/1066 | Ongentys | Liechtenstein | 30.6.2016 |
| EU/1/15/1067 | Lopinavir/Ritonavir Mylan | Liechtenstein | 29.2.2016 |
| EU/1/15/1067 | Lopinavir/Ritonavir Mylan | Norway | 21.1.2016 |
| EU/1/15/1067 | Lopinavir/Ritonavir Mylan | Iceland | 20.1.2016 |
| EU/1/15/1068 | Wakix | Liechtenstein | 30.4.2016 |
| EU/1/15/1068 | Wakix | Norway | 19.4.2016 |
| EU/1/15/1068 | Wakix | Iceland | 22.4.2016 |
| EU/1/15/1069 | Episalvan | Liechtenstein | 29.2.2016 |
| EU/1/15/1069 | Episalvan | Norway | 20.1.2016 |
| EU/1/15/1069 | Episalvan | Iceland | 19.1.2016 |
| EU/1/15/1070 | Oncaspar | Liechtenstein | 29.2.2016 |
| EU/1/15/1070 | Oncaspar | Norway | 25.1.2016 |
| EU/1/15/1070 | Oncaspar | Iceland | 25.1.2016 |
| EU/1/15/1071 | Pemetrexed Accord | Liechtenstein | 29.2.2016 |
| EU/1/15/1071 | Pemetrexed Accord | Norway | 25.1.2016 |
| EU/1/15/1071 | Pemetrexed Accord | Iceland | 25.1.2016 |
| EU/1/15/1072 | Spectrila | Liechtenstein | 29.2.2016 |
| EU/1/15/1072 | Spectrila | Norway | 19.1.2016 |
| EU/1/15/1072 | Spectrila | Iceland | 19.1.2016 |
| EU/1/15/1073 | Briviact | Liechtenstein | 29.2.2016 |
| EU/1/15/1073 | Briviact | Norway | 21.1.2016 |
| EU/1/15/1073 | Briviact | Iceland | 25.1.2016 |
| EU/1/15/1074 | Benepali | Liechtenstein | 29.2.2016 |
| EU/1/15/1074 | Benepali | Norway | 19.1.2016 |
| EU/1/15/1074 | Benepali | Iceland | 19.1.2016 |
| EU/1/15/1075 | Feraccru | Liechtenstein | 29.2.2016 |
| EU/1/15/1075 | Feraccru | Norway | 7.3.2016 |
| EU/1/15/1075 | Feraccru | Iceland | 18.3.2016 |
| EU/1/15/1076 | Kovaltry | Liechtenstein | 29.2.2016 |
| EU/1/15/1076 | Kovaltry | Norway | 10.3.2016 |
| EU/1/15/1076 | Kovaltry | Iceland | 16.3.2016 |
| EU/1/15/1077 | Iblias | Liechtenstein | 29.2.2016 |
| EU/1/15/1077 | Iblias | Norway | 10.3.2016 |
| EU/1/15/1077 | Iblias | Iceland | 16.3.2016 |
| EU/1/15/1079 | Vaxelis | Liechtenstein | 29.2.2016 |
| EU/1/15/1079 | Vaxelis | Norway | 29.2.2016 |
| EU/1/15/1079 | Vaxelis | Iceland | 1.3.2016 |
| EU/1/15/1080 | Zurampic | Liechtenstein | 29.2.2016 |
| EU/1/15/1080 | Zurampic | Norway | 3.3.2016 |
| EU/1/15/1080 | Zurampic | Iceland | 16.3.2016 |
| EU/1/15/1081 | Caspofungin Accord | Liechtenstein | 29.2.2016 |
| EU/1/15/1081 | Caspofungin Accord | Norway | 29.2.2016 |
| EU/1/15/1081 | Caspofungin Accord | Iceland | 25.2.2016 |
| EU/1/15/1082 | Galafold | Liechtenstein | 30.6.2016 |
| EU/1/15/1082 | Galafold | Norway | 14.6.2016 |
| EU/1/15/1082 | Galafold | Iceland | 14.6.2016 |
| EU/1/15/1083 | Uptravi | Liechtenstein | 30.6.2016 |
| EU/1/15/1083 | Uptravi | Iceland | 26.5.2016 |
| EU/1/15/1083 | Uptravi | Norway | 30.5.2016 |
| EU/1/15/1084 | Portrazza | Liechtenstein | 29.2.2016 |
| EU/1/15/1084 | Portrazza | Norway | 26.2.2016 |
| EU/1/15/1084 | Portrazza | Iceland | 15.3.2016 |
| EU/1/15/1085 | Taltz | Liechtenstein | 30.4.2016 |
| EU/1/15/1085 | Taltz | Norway | 9.5.2016 |
| EU/1/15/1085 | Taltz | Iceland | 20.5.2016 |
| EU/1/16/1086 | Tagrisso | Liechtenstein | 29.2.2016 |
| EU/1/16/1086 | Tagrisso | Norway | 19.2.2016 |
| EU/1/16/1086 | Tagrisso | Iceland | 11.2.2016 |
| EU/1/16/1087 | Coagadex | Liechtenstein | 30.4.2016 |
| EU/1/16/1087 | Coagadex | Norway | 1.4.2016 |
| EU/1/16/1087 | Coagadex | Iceland | 22.3.2016 |
| EU/1/16/1088 | Empliciti | Liechtenstein | 30.6.2016 |
| EU/1/16/1088 | Empliciti | Norway | 24.5.2016 |
| EU/1/16/1088 | Empliciti | Iceland | 19.5.2016 |
| EU/1/16/1089 | Pandemic influenza vaccine H5N1 MedImmune | Liechtenstein | 30.6.2016 |
| EU/1/16/1089 | Pandemic influenza vaccine H5N1 MedImmune | Norway | 30.5.2016 |
| EU/1/16/1089 | Pandemic influenza vaccine H5N1 MedImmune | Iceland | 30.5.2016 |
| EU/1/16/1090 | Rasagiline Mylan | Liechtenstein | 30.4.2016 |
| EU/1/16/1090 | Rasagiline Mylan | Norway | 19.4.2016 |
| EU/1/16/1090 | Rasagiline Mylan | Iceland | 22.4.2016 |
| EU/1/16/1092 | Amlodipin/Valsartan Mylan | Liechtenstein | 30.4.2016 |
| EU/1/16/1092 | Amlodipine/Valsartan Mylan | Norway | 11.4.2016 |
| EU/1/16/1092 | Amlodipine/Valsartan Mylan | Iceland | 31.3.2016 |
| EU/1/16/1093 | Zonisamide Mylan | Liechtenstein | 30.4.2016 |
| EU/1/16/1093 | Zonisamide Mylan | Norway | 19.4.2016 |
| EU/1/16/1093 | Zonisamide Mylan | Iceland | 22.4.2016 |
| EU/1/16/1095 | Idelvion | Liechtenstein | 30.6.2016 |
| EU/1/16/1095 | Idelvion | Norway | 30.5.2016 |
| EU/1/16/1095 | Idelvion | Iceland | 23.5.2016 |
| EU/1/16/1096 | Lonsurf | Liechtenstein | 30.4.2016 |
| EU/1/16/1096 | Lonsurf | Norway | 9.5.2016 |
| EU/1/16/1096 | Lonsurf | Iceland | 20.5.2016 |
| EU/1/16/1097 | Strimvelis | Liechtenstein | 30.6.2016 |
| EU/1/16/1097 | Strimvelis | Norway | 9.6.2016 |
| EU/1/16/1097 | Strimvelis | Iceland | 16.6.2016 |
| EU/1/16/1098 | Alprolix | Liechtenstein | 30.6.2016 |
| EU/1/16/1098 | Alprolix | Norway | 25.5.2016 |
| EU/1/16/1098 | Alprolix | Iceland | 20.5.2016 |
| EU/1/16/1099 | Descovy | Liechtenstein | 30.4.2016 |
| EU/1/16/1099 | Descovy | Norway | 27.4.2016 |
| EU/1/16/1099 | Descovy | Iceland | 18.5.2016 |
| EU/1/16/1100 | Palonosetron Hospira | Liechtenstein | 30.4.2016 |
| EU/1/16/1100 | Palonosetron Hospira | Norway | 19.4.2016 |
| EU/1/16/1100 | Palonosetron Hospira | Iceland | 27.4.2016 |
| EU/1/16/1101 | Darzalex | Liechtenstein | 30.6.2016 |
| EU/1/16/1101 | Darzalex | Norway | 30.5.2016 |
| EU/1/16/1101 | Darzalex | Iceland | 30.5.2016 |
| EU/1/16/1103 | Neparvis | Liechtenstein | 30.6.2016 |
| EU/1/16/1103 | Neparvis | Norway | 24.6.2016 |
| EU/1/16/1104 | Palonosetron Accord | Liechtenstein | 30.6.2016 |
| EU/1/16/1104 | Palonosteron Accord | Norway | 14.6.2016 |
| EU/1/16/1104 | Palonosetron Accord | Iceland | 14.6.2016 |
| EU/1/16/1106 | Flixabi | Liechtenstein | 30.6.2016 |
| EU/1/16/1106 | Flixabi | Norway | 17.6.2016 |
| EU/1/16/1106 | Flixabi | Iceland | 15.6.2016 |
| EU/1/16/1109 | Zavicefta | Liechtenstein | 30.6.2016 |
| EU/1/16/1112 | Odefsey | Liechtenstein | 30.6.2016 |
| EU/1/16/1112 | Odefsey | Norway | 24.6.2016 |
| EU/2/15/192 | Velactis | Norway | 4.1.2016 |
| EU/2/15/193 | Imrestor | Norway | 5.1.2016 |
| EU/2/15/193 | Imrestor | Iceland | 4.1.2016 |
| EU/2/16/194 | Evalon | Liechtenstein | 30.4.2016 |
| EU/2/16/194 | Evalon | Norway | 11.5.2016 |
| EU/2/16/194 | Evalon | Iceland | 13.5.2016 |
| EU/2/16/195 | Letifend | Liechtenstein | 30.4.2016 |
| EU/2/16/195 | Letifend | Norway | 27.4.2016 |
| EU/2/16/195 | Letifend | Iceland | 18.5.2016 |

EU-Number

Product

Country

Date of authorisation

EU/1/15/1053

Neofordex

Liechtenstein

30.4.2016

EU/1/15/1053

Neofordex

Iceland

31.3.2016

EU/1/15/1053

Neofordex

Norway

1.4.2016

EU/1/15/1063

Pemetrexed Actavis

Liechtenstein

29.2.2016

EU/1/15/1063

Pemetrexed Actavis

Norway

25.1.2016

EU/1/15/1063

Pemetrexed Actavis

Iceland

25.1.2016

EU/1/15/1064

Imlygic

Liechtenstein

29.2.2016

EU/1/15/1064

Imlygic

Norway

20.1.2016

EU/1/15/1064

Imlygic

Iceland

14.1.2016

EU/1/15/1065

Eptifibatid Accord

Liechtenstein

29.2.2016

EU/1/15/1065

Eptifibatide Accord

Norway

18.1.2016

EU/1/15/1065

Eptifibatide Accord

Iceland

14.1.2016

EU/1/15/1066

Ongentys

Liechtenstein

30.6.2016

EU/1/15/1067

Lopinavir/Ritonavir Mylan

Liechtenstein

29.2.2016

EU/1/15/1067

Lopinavir/Ritonavir Mylan

Norway

21.1.2016

EU/1/15/1067

Lopinavir/Ritonavir Mylan

Iceland

20.1.2016

EU/1/15/1068

Wakix

Liechtenstein

30.4.2016

EU/1/15/1068

Wakix

Norway

19.4.2016

EU/1/15/1068

Wakix

Iceland

22.4.2016

EU/1/15/1069

Episalvan

Liechtenstein

29.2.2016

EU/1/15/1069

Episalvan

Norway

20.1.2016

EU/1/15/1069

Episalvan

Iceland

19.1.2016

EU/1/15/1070

Oncaspar

Liechtenstein

29.2.2016

EU/1/15/1070

Oncaspar

Norway

25.1.2016

EU/1/15/1070

Oncaspar

Iceland

25.1.2016

EU/1/15/1071

Pemetrexed Accord

Liechtenstein

29.2.2016

EU/1/15/1071

Pemetrexed Accord

Norway

25.1.2016

EU/1/15/1071

Pemetrexed Accord

Iceland

25.1.2016

EU/1/15/1072

Spectrila

Liechtenstein

29.2.2016

EU/1/15/1072

Spectrila

Norway

19.1.2016

EU/1/15/1072

Spectrila

Iceland

19.1.2016

EU/1/15/1073

Briviact

Liechtenstein

29.2.2016

EU/1/15/1073

Briviact

Norway

21.1.2016

EU/1/15/1073

Briviact

Iceland

25.1.2016

EU/1/15/1074

Benepali

Liechtenstein

29.2.2016

EU/1/15/1074

Benepali

Norway

19.1.2016

EU/1/15/1074

Benepali

Iceland

19.1.2016

EU/1/15/1075

Feraccru

Liechtenstein

29.2.2016

EU/1/15/1075

Feraccru

Norway

7.3.2016

EU/1/15/1075

Feraccru

Iceland

18.3.2016

EU/1/15/1076

Kovaltry

Liechtenstein

29.2.2016

EU/1/15/1076

Kovaltry

Norway

10.3.2016

EU/1/15/1076

Kovaltry

Iceland

16.3.2016

EU/1/15/1077

Iblias

Liechtenstein

29.2.2016

EU/1/15/1077

Iblias

Norway

10.3.2016

EU/1/15/1077

Iblias

Iceland

16.3.2016

EU/1/15/1079

Vaxelis

Liechtenstein

29.2.2016

EU/1/15/1079

Vaxelis

Norway

29.2.2016

EU/1/15/1079

Vaxelis

Iceland

1.3.2016

EU/1/15/1080

Zurampic

Liechtenstein

29.2.2016

EU/1/15/1080

Zurampic

Norway

3.3.2016

EU/1/15/1080

Zurampic

Iceland

16.3.2016

EU/1/15/1081

Caspofungin Accord

Liechtenstein

29.2.2016

EU/1/15/1081

Caspofungin Accord

Norway

29.2.2016

EU/1/15/1081

Caspofungin Accord

Iceland

25.2.2016

EU/1/15/1082

Galafold

Liechtenstein

30.6.2016

EU/1/15/1082

Galafold

Norway

14.6.2016

EU/1/15/1082

Galafold

Iceland

14.6.2016

EU/1/15/1083

Uptravi

Liechtenstein

30.6.2016

EU/1/15/1083

Uptravi

Iceland

26.5.2016

EU/1/15/1083

Uptravi

Norway

30.5.2016

EU/1/15/1084

Portrazza

Liechtenstein

29.2.2016

EU/1/15/1084

Portrazza

Norway

26.2.2016

EU/1/15/1084

Portrazza

Iceland

15.3.2016

EU/1/15/1085

Taltz

Liechtenstein

30.4.2016

EU/1/15/1085

Taltz

Norway

9.5.2016

EU/1/15/1085

Taltz

Iceland

20.5.2016

EU/1/16/1086

Tagrisso

Liechtenstein

29.2.2016

EU/1/16/1086

Tagrisso

Norway

19.2.2016

EU/1/16/1086

Tagrisso

Iceland

11.2.2016

EU/1/16/1087

Coagadex

Liechtenstein

30.4.2016

EU/1/16/1087

Coagadex

Norway

1.4.2016

EU/1/16/1087

Coagadex

Iceland

22.3.2016

EU/1/16/1088

Empliciti

Liechtenstein

30.6.2016

EU/1/16/1088

Empliciti

Norway

24.5.2016

EU/1/16/1088

Empliciti

Iceland

19.5.2016

EU/1/16/1089

Pandemic influenza vaccine H5N1 MedImmune

Liechtenstein

30.6.2016

EU/1/16/1089

Pandemic influenza vaccine H5N1 MedImmune

Norway

30.5.2016

EU/1/16/1089

Pandemic influenza vaccine H5N1 MedImmune

Iceland

30.5.2016

EU/1/16/1090

Rasagiline Mylan

Liechtenstein

30.4.2016

EU/1/16/1090

Rasagiline Mylan

Norway

19.4.2016

EU/1/16/1090

Rasagiline Mylan

Iceland

22.4.2016

EU/1/16/1092

Amlodipin/Valsartan Mylan

Liechtenstein

30.4.2016

EU/1/16/1092

Amlodipine/Valsartan Mylan

Norway

11.4.2016

EU/1/16/1092

Amlodipine/Valsartan Mylan

Iceland

31.3.2016

EU/1/16/1093

Zonisamide Mylan

Liechtenstein

30.4.2016

EU/1/16/1093

Zonisamide Mylan

Norway

19.4.2016

EU/1/16/1093

Zonisamide Mylan

Iceland

22.4.2016

EU/1/16/1095

Idelvion

Liechtenstein

30.6.2016

EU/1/16/1095

Idelvion

Norway

30.5.2016

EU/1/16/1095

Idelvion

Iceland

23.5.2016

EU/1/16/1096

Lonsurf

Liechtenstein

30.4.2016

EU/1/16/1096

Lonsurf

Norway

9.5.2016

EU/1/16/1096

Lonsurf

Iceland

20.5.2016

EU/1/16/1097

Strimvelis

Liechtenstein

30.6.2016

EU/1/16/1097

Strimvelis

Norway

9.6.2016

EU/1/16/1097

Strimvelis

Iceland

16.6.2016

EU/1/16/1098

Alprolix

Liechtenstein

30.6.2016

EU/1/16/1098

Alprolix

Norway

25.5.2016

EU/1/16/1098

Alprolix

Iceland

20.5.2016

EU/1/16/1099

Descovy

Liechtenstein

30.4.2016

EU/1/16/1099

Descovy

Norway

27.4.2016

EU/1/16/1099

Descovy

Iceland

18.5.2016

EU/1/16/1100

Palonosetron Hospira

Liechtenstein

30.4.2016

EU/1/16/1100

Palonosetron Hospira

Norway

19.4.2016

EU/1/16/1100

Palonosetron Hospira

Iceland

27.4.2016

EU/1/16/1101

Darzalex

Liechtenstein

30.6.2016

EU/1/16/1101

Darzalex

Norway

30.5.2016

EU/1/16/1101

Darzalex

Iceland

30.5.2016

EU/1/16/1103

Neparvis

Liechtenstein

30.6.2016

EU/1/16/1103

Neparvis

Norway

24.6.2016

EU/1/16/1104

Palonosetron Accord

Liechtenstein

30.6.2016

EU/1/16/1104

Palonosteron Accord

Norway

14.6.2016

EU/1/16/1104

Palonosetron Accord

Iceland

14.6.2016

EU/1/16/1106

Flixabi

Liechtenstein

30.6.2016

EU/1/16/1106

Flixabi

Norway

17.6.2016

EU/1/16/1106

Flixabi

Iceland

15.6.2016

EU/1/16/1109

Zavicefta

Liechtenstein

30.6.2016

EU/1/16/1112

Odefsey

Liechtenstein

30.6.2016

EU/1/16/1112

Odefsey

Norway

24.6.2016

EU/2/15/192

Velactis

Norway

4.1.2016

EU/2/15/193

Imrestor

Norway

5.1.2016

EU/2/15/193

Imrestor

Iceland

4.1.2016

EU/2/16/194

Evalon

Liechtenstein

30.4.2016

EU/2/16/194

Evalon

Norway

11.5.2016

EU/2/16/194

Evalon

Iceland

13.5.2016

EU/2/16/195

Letifend

Liechtenstein

30.4.2016

EU/2/16/195

Letifend

Norway

27.4.2016

EU/2/16/195

Letifend

Iceland

18.5.2016

---

ANNEX II

List of renewed marketing authorisations

The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 January-30 June 2016:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/05/323 | ProQuad | Iceland | 4.1.2016 |
| EU/1/05/323 | ProQuad | Norway | 11.1.2016 |
| EU/1/05/330 | Rotarix | Liechtenstein | 29.2.2016 |
| EU/1/05/330 | Rotarix | Iceland | 20.1.2016 |
| EU/1/05/330 | Rotarix | Norway | 20.1.2016 |
| EU/1/05/331 | Neupro | Liechtenstein | 29.2.2016 |
| EU/1/05/331 | Neupro | Iceland | 28.1.2016 |
| EU/1/05/331 | Neupro | Norway | 4.2.2016 |
| EU/1/06/334 | Evoltra | Liechtenstein | 29.2.2016 |
| EU/1/06/334 | Evoltra | Norway | 19.1.2016 |
| EU/1/06/334 | Evoltra | Iceland | 20.1.2016 |
| EU/1/06/336 | Tygacil | Liechtenstein | 29.2.2016 |
| EU/1/06/336 | Tygacil | Norway | 18.3.2016 |
| EU/1/06/336 | Tygacil | Iceland | 18.3.2016 |
| EU/1/06/341 | Zostavax | Liechtenstein | 29.2.2016 |
| EU/1/06/341 | Zostavax | Norway | 29.2.2016 |
| EU/1/06/341 | Zostavax | Iceland | 18.2.2016 |
| EU/1/06/346 | Tysabri | Norway | 29.4.2016 |
| EU/1/06/346 | Tysabri | Iceland | 12.5.2016 |
| EU/1/06/354 | Competact | Liechtenstein | 30.4.2016 |
| EU/1/06/354 | Competact | Norway | 12.5.2016 |
| EU/1/06/354 | Competact | Iceland | 18.5.2016 |
| EU/1/06/356 | Exjade | Liechtenstein | 30.4.2016 |
| EU/1/06/356 | Exjade | Norway | 2.5.2016 |
| EU/1/06/356 | Exjade | Iceland | 12.5.2016 |
| EU/1/09/543 | Cayston | Liechtenstein | 30.6.2016 |
| EU/1/09/543 | Cayston | Norway | 14.6.2016 |
| EU/1/09/543 | Cayston | Iceland | 13.6.2016 |
| EU/1/10/652 | TOBI Podhaler | Liechtenstein | 29.2.2016 |
| EU/1/10/652 | TOBI Podhaler | Norway | 1.3.2016 |
| EU/1/10/652 | TOBI Podhaler | Iceland | 17.3.2016 |
| EU/1/11/671 | Xiapex | Liechtenstein | 29.2.2016 |
| EU/1/11/671 | Xiapex | Norway | 25.1.2016 |
| EU/1/11/671 | Xiapex | Iceland | 27.1.2016 |
| EU/1/11/672 | Xeplion | Norway | 11.1.2016 |
| EU/1/11/672 | Xeplion | Iceland | 4.1.2016 |
| EU/1/11/674 | Repso | Liechtenstein | 29.2.2016 |
| EU/1/11/674 | Repso | Norway | 25.1.2016 |
| EU/1/11/674 | Repso | Iceland | 20.1.2016 |
| EU/1/11/679 | Pravafenix | Liechtenstein | 29.2.2016 |
| EU/1/11/679 | Pravafenix | Norway | 2.2.2016 |
| EU/1/11/679 | Pravafenix | Iceland | 26.1.2016 |
| EU/1/11/681 | Trobalt | Liechtenstein | 29.2.2016 |
| EU/1/11/681 | Trobalt | Norway | 25.1.2016 |
| EU/1/11/681 | Trobalt | Iceland | 26.1.2016 |
| EU/1/11/682 | Methylthioninium chloride Proveblue | Norway | 29.2.2016 |
| EU/1/11/682 | Methylthioninium chloride Proveblue | Iceland | 16.2.2016 |
| EU/1/11/682 | Methylthioniniumchlorid Proveblue | Liechtenstein | 29.2.2016 |
| EU/1/11/685 | Ibandronic acid Sandoz | Norway | 11.5.2016 |
| EU/1/11/685 | Ibandronic acid Sandoz | Iceland | 27.4.2016 |
| EU/1/11/687 | Hizentra | Liechtenstein | 29.2.2016 |
| EU/1/11/687 | Hizentra | Norway | 29.2.2016 |
| EU/1/11/687 | Hizentra | Iceland | 17.3.2016 |
| EU/1/11/688 | Cinryze | Liechtenstein | 30.6.2016 |
| EU/1/11/688 | Cinryze | Norway | 22.6.2016 |
| EU/1/11/688 | Cinryze | Iceland | 13.6.2016 |
| EU/1/11/690 | Zoely | Liechtenstein | 30.4.2016 |
| EU/1/11/690 | Zoely | Norway | 29.4.2016 |
| EU/1/11/690 | Zoely | Iceland | 18.5.2016 |
| EU/1/11/691 | Eliquis | Liechtenstein | 29.2.2016 |
| EU/1/11/691 | Eliquis | Norway | 2.2.2016 |
| EU/1/11/691 | Eliquis | Iceland | 26.1.2016 |
| EU/1/11/692 | Yellox | Liechtenstein | 29.2.2016 |
| EU/1/11/692 | Yellox | Norway | 2.2.2016 |
| EU/1/11/692 | Yellox | Iceland | 19.1.2016 |
| EU/1/11/693 | Rivastigmin Actavis | Norway | 3.3.2016 |
| EU/1/11/693 | Rivastigmine Actavis | Liechtenstein | 29.2.2016 |
| EU/1/11/693 | Rivastigmine Actavis | Iceland | 15.3.2016 |
| EU/1/11/694 | Nulojix | Liechtenstein | 29.2.2016 |
| EU/1/11/694 | Nulojix | Norway | 26.2.2016 |
| EU/1/11/694 | Nulojix | Iceland | 17.3.2016 |
| EU/1/11/695 | Leganto | Liechtenstein | 29.2.2016 |
| EU/1/11/695 | Leganto | Norway | 1.2.2016 |
| EU/1/11/695 | Leganto | Iceland | 26.1.2016 |
| EU/1/11/696 | Bydureon | Liechtenstein | 29.2.2016 |
| EU/1/11/696 | Bydureon | Norway | 10.3.2016 |
| EU/1/11/696 | Bydureon | Iceland | 17.3.2016 |
| EU/1/11/697 | Temozolomide SUN | Liechtenstein | 30.4.2016 |
| EU/1/11/697 | Temozolomide SUN | Norway | 29.4.2016 |
| EU/1/11/697 | Temozolomide SUN | Iceland | 18.5.2016 |
| EU/1/11/698 | Yervoy | Liechtenstein | 30.4.2016 |
| EU/1/11/698 | Yervoy | Norway | 29.4.2016 |
| EU/1/11/698 | Yervoy | Iceland | 18.5.2016 |
| EU/1/11/699 | Fampyra | Liechtenstein | 30.6.2016 |
| EU/1/11/699 | Fampyra | Iceland | 15.6.2016 |
| EU/1/11/700 | Benlysta | Liechtenstein | 29.2.2016 |
| EU/1/11/700 | Benlysta | Norway | 26.2.2016 |
| EU/1/11/700 | Benlysta | Iceland | 18.3.2016 |
| EU/1/11/702 | Levetiracetam ratiopharm | Liechtenstein | 30.4.2016 |
| EU/1/11/702 | Levetiracetam ratiopharm | Norway | 18.5.2016 |
| EU/1/11/702 | Levetiracetam ratiopharm | Iceland | 19.5.2016 |
| EU/1/11/703 | Xgeva | Liechtenstein | 30.6.2016 |
| EU/1/11/703 | Xgeva | Norway | 18.5.2016 |
| EU/1/11/703 | Xgeva | Iceland | 13.5.2016 |
| EU/1/11/704 | Victrelis | Liechtenstein | 29.2.2016 |
| EU/1/11/704 | Victrelis | Iceland | 17.3.2016 |
| EU/1/11/704 | Victrelis | Norway | 3.3.2016 |
| EU/1/11/705 | Vibativ | Liechtenstein | 30.6.2016 |
| EU/1/11/705 | Vibativ | Iceland | 13.6.2016 |
| EU/1/11/705 | Vibativ | Norway | 9.6.2016 |
| EU/1/11/706 | Levodopa/Carbidopa/Entacapone Orion | Liechtenstein | 30.6.2016 |
| EU/1/11/706 | Levodopa/Carbidopa/Entacapone Orion | Iceland | 15.6.2016 |
| EU/1/11/707 | Trajenta | Liechtenstein | 30.4.2016 |
| EU/1/11/707 | Trajenta | Norway | 19.4.2016 |
| EU/1/11/707 | Trajenta | Iceland | 31.3.2016 |
| EU/1/11/708 | Entacapone Orion | Liechtenstein | 30.4.2016 |
| EU/1/11/708 | Entacapone Orion | Norway | 21.4.2016 |
| EU/1/11/708 | Entacapone Orion | Iceland | 26.4.2016 |
| EU/1/11/709 | Buccolam | Liechtenstein | 30.6.2016 |
| EU/1/11/709 | Buccolam | Norway | 24.6.2016 |
| EU/1/11/709 | Buccolam | Iceland | 13.6.2016 |
| EU/1/11/714 | Zytiga | Liechtenstein | 30.6.2016 |
| EU/1/11/714 | Zytiga | Norway | 14.6.2016 |
| EU/1/11/714 | Zytiga | Iceland | 13.6.2016 |
| EU/1/11/718 | Dexdor | Liechtenstein | 30.6.2016 |
| EU/1/11/718 | Dexdor | Norway | 20.6.2016 |
| EU/1/11/718 | Dexdor | Iceland | 13.6.2016 |
| EU/1/11/719 | Telmisartan Teva Pharma | Liechtenstein | 30.6.2016 |
| EU/1/11/719 | Telmisartan Teva Pharma | Norway | 23.6.2016 |
| EU/1/11/749 | Caprelsa | Norway | 14.1.2016 |
| EU/1/11/749 | Caprelsa | Iceland | 14.1.2016 |
| EU/1/12/764 | Pixuvri | Liechtenstein | 30.4.2016 |
| EU/1/12/764 | Pixuvri | Norway | 1.4.2016 |
| EU/1/12/764 | Pixuvri | Iceland | 31.3.2016 |
| EU/1/13/818 | Bosulif | Norway | 14.1.2016 |
| EU/1/13/818 | Bosulif | Iceland | 13.1.2016 |
| EU/1/13/848 | Erivedge | Norway | 16.6.2016 |
| EU/1/13/848 | Erivedge | Iceland | 15.6.2016 |
| EU/1/13/875 | Deltyba | Norway | 29.3.2016 |
| EU/1/13/875 | Deltyba | Iceland | 22.3.2016 |
| EU/1/13/890 | Cometriq | Liechtenstein | 29.2.2016 |
| EU/1/13/890 | Cometriq | Norway | 20.1.2016 |
| EU/1/13/890 | Cometriq | Iceland | 19.1.2016 |
| EU/1/13/901 | Sirturo | Liechtenstein | 29.2.2016 |
| EU/1/13/901 | Sirturo | Norway | 14.1.2016 |
| EU/1/13/901 | Sirturo | Iceland | 13.1.2016 |
| EU/1/14/987 | Holoclar | Iceland | 4.1.2016 |
| EU/1/15/999 | Zykadia | Liechtenstein | 30.4.2016 |
| EU/1/15/999 | Zykadia | Norway | 6.4.2016 |
| EU/1/15/999 | Zykadia | Iceland | 31.3.2016 |
| EU/2/06/061 | Nobilis Influenza H5N2 | Norway | 28.6.2016 |
| EU/2/10/107 | Veraflox | Liechtenstein | 29.2.2016 |
| EU/2/10/107 | Veraflox | Norway | 13.1.2016 |
| EU/2/10/107 | Veraflox | Iceland | 15.1.2016 |
| EU/2/10/115 | Comfortis | Liechtenstein | 29.2.2016 |
| EU/2/10/115 | Comfortis | Norway | 18.1.2016 |
| EU/2/10/115 | Comfortis | Iceland | 15.1.2016 |
| EU/2/10/116 | Melosus | Liechtenstein | 29.2.2016 |
| EU/2/10/116 | Melosus | Norway | 22.1.2016 |
| EU/2/10/116 | Melosus | Iceland | 22.1.2016 |
| EU/2/10/118 | Activyl | Liechtenstein | 29.2.2016 |
| EU/2/10/118 | Activyl | Norway | 29.1.2016 |
| EU/2/10/118 | Activyl | Iceland | 15.1.2016 |
| EU/2/10/119 | Cimalgex | Liechtenstein | 29.2.2016 |
| EU/2/10/119 | Cimalgex | Norway | 19.1.2016 |
| EU/2/10/119 | Cimalgex | Iceland | 15.1.2016 |
| EU/2/11/120 | Zulvac 1 + 8 Ovis | Liechtenstein | 29.2.2016 |
| EU/2/11/120 | Zulvac 1 + 8 Ovis | Norway | 19.1.2016 |
| EU/2/11/120 | Zulvac 1 + 8 Ovis | Iceland | 15.1.2016 |
| EU/2/11/121 | CaniLeish | Liechtenstein | 29.2.2016 |
| EU/2/11/121 | CaniLeish | Norway | 18.1.2016 |
| EU/2/11/121 | CaniLeish | Iceland | 15.1.2016 |
| EU/2/11/122 | Bluevac BTV8 | Liechtenstein | 30.4.2016 |
| EU/2/11/122 | Bluevac BTV8 | Norway | 29.3.2016 |
| EU/2/11/122 | Bluevac BTV8 | Iceland | 29.3.2016 |
| EU/2/11/123 | Procox | Liechtenstein | 29.2.2016 |
| EU/2/11/123 | Procox | Norway | 20.1.2016 |
| EU/2/11/123 | Procox | Iceland | 20.1.2016 |
| EU/2/11/124 | Zuprevo | Liechtenstein | 30.6.2016 |
| EU/2/11/124 | Zuprevo | Norway | 1.6.2016 |
| EU/2/11/124 | Zuprevo | Iceland | 26.5.2016 |
| EU/2/11/125 | Certifect | Liechtenstein | 30.4.2016 |
| EU/2/11/125 | Certifect | Norway | 4.5.2016 |
| EU/2/11/125 | Certifect | Iceland | 12.5.2016 |
| EU/2/11/126 | MS-H Impfstoff | Liechtenstein | 30.6.2016 |
| EU/2/11/126 | MS-H Vaccine | Iceland | 23.5.2016 |
| EU/2/11/126 | MS-H-Vaksine | Norway | 24.5.2016 |
| EU/2/11/128 | Emdocam | Liechtenstein | 30.6.2016 |
| EU/2/11/128 | Emdocam | Norway | 27.6.2016 |
| EU/2/11/129 | Proteq West Nile | Liechtenstein | 30.6.2016 |
| EU/2/11/129 | Proteq West Nile | Norway | 24.5.2016 |
| EU/2/11/129 | Proteq West Nile | Iceland | 23.5.2016 |
| EU/2/11/130 | Zulvac 1 Bovis | Liechtenstein | 30.4.2016 |
| EU/2/11/130 | Zulvac 1 Bovis | Norway | 2.5.2016 |
| EU/2/11/130 | Zulvac 1 Bovis | Iceland | 13.5.2016 |
| EU/2/11/131 | Zulvac 1 Ovis | Liechtenstein | 30.4.2016 |
| EU/2/11/131 | Zulvac 1 Ovis | Norway | 2.5.2016 |
| EU/2/11/131 | Zulvac 1 Ovis | Iceland | 13.5.2016 |

EU-Number

Product

Country

Date of authorisation

EU/1/05/323

ProQuad

Iceland

4.1.2016

EU/1/05/323

ProQuad

Norway

11.1.2016

EU/1/05/330

Rotarix

Liechtenstein

29.2.2016

EU/1/05/330

Rotarix

Iceland

20.1.2016

EU/1/05/330

Rotarix

Norway

20.1.2016

EU/1/05/331

Neupro

Liechtenstein

29.2.2016

EU/1/05/331

Neupro

Iceland

28.1.2016

EU/1/05/331

Neupro

Norway

4.2.2016

EU/1/06/334

Evoltra

Liechtenstein

29.2.2016

EU/1/06/334

Evoltra

Norway

19.1.2016

EU/1/06/334

Evoltra

Iceland

20.1.2016

EU/1/06/336

Tygacil

Liechtenstein

29.2.2016

EU/1/06/336

Tygacil

Norway

18.3.2016

EU/1/06/336

Tygacil

Iceland

18.3.2016

EU/1/06/341

Zostavax

Liechtenstein

29.2.2016

EU/1/06/341

Zostavax

Norway

29.2.2016

EU/1/06/341

Zostavax

Iceland

18.2.2016

EU/1/06/346

Tysabri

Norway

29.4.2016

EU/1/06/346

Tysabri

Iceland

12.5.2016

EU/1/06/354

Competact

Liechtenstein

30.4.2016

EU/1/06/354

Competact

Norway

12.5.2016

EU/1/06/354

Competact

Iceland

18.5.2016

EU/1/06/356

Exjade

Liechtenstein

30.4.2016

EU/1/06/356

Exjade

Norway

2.5.2016

EU/1/06/356

Exjade

Iceland

12.5.2016

EU/1/09/543

Cayston

Liechtenstein

30.6.2016

EU/1/09/543

Cayston

Norway

14.6.2016

EU/1/09/543

Cayston

Iceland

13.6.2016

EU/1/10/652

TOBI Podhaler

Liechtenstein

29.2.2016

EU/1/10/652

TOBI Podhaler

Norway

1.3.2016

EU/1/10/652

TOBI Podhaler

Iceland

17.3.2016

EU/1/11/671

Xiapex

Liechtenstein

29.2.2016

EU/1/11/671

Xiapex

Norway

25.1.2016

EU/1/11/671

Xiapex

Iceland

27.1.2016

EU/1/11/672

Xeplion

Norway

11.1.2016

EU/1/11/672

Xeplion

Iceland

4.1.2016

EU/1/11/674

Repso

Liechtenstein

29.2.2016

EU/1/11/674

Repso

Norway

25.1.2016

EU/1/11/674

Repso

Iceland

20.1.2016

EU/1/11/679

Pravafenix

Liechtenstein

29.2.2016

EU/1/11/679

Pravafenix

Norway

2.2.2016

EU/1/11/679

Pravafenix

Iceland

26.1.2016

EU/1/11/681

Trobalt

Liechtenstein

29.2.2016

EU/1/11/681

Trobalt

Norway

25.1.2016

EU/1/11/681

Trobalt

Iceland

26.1.2016

EU/1/11/682

Methylthioninium chloride Proveblue

Norway

29.2.2016

EU/1/11/682

Methylthioninium chloride Proveblue

Iceland

16.2.2016

EU/1/11/682

Methylthioniniumchlorid Proveblue

Liechtenstein

29.2.2016

EU/1/11/685

Ibandronic acid Sandoz

Norway

11.5.2016

EU/1/11/685

Ibandronic acid Sandoz

Iceland

27.4.2016

EU/1/11/687

Hizentra

Liechtenstein

29.2.2016

EU/1/11/687

Hizentra

Norway

29.2.2016

EU/1/11/687

Hizentra

Iceland

17.3.2016

EU/1/11/688

Cinryze

Liechtenstein

30.6.2016

EU/1/11/688

Cinryze

Norway

22.6.2016

EU/1/11/688

Cinryze

Iceland

13.6.2016

EU/1/11/690

Zoely

Liechtenstein

30.4.2016

EU/1/11/690

Zoely

Norway

29.4.2016

EU/1/11/690

Zoely

Iceland

18.5.2016

EU/1/11/691

Eliquis

Liechtenstein

29.2.2016

EU/1/11/691

Eliquis

Norway

2.2.2016

EU/1/11/691

Eliquis

Iceland

26.1.2016

EU/1/11/692

Yellox

Liechtenstein

29.2.2016

EU/1/11/692

Yellox

Norway

2.2.2016

EU/1/11/692

Yellox

Iceland

19.1.2016

EU/1/11/693

Rivastigmin Actavis

Norway

3.3.2016

EU/1/11/693

Rivastigmine Actavis

Liechtenstein

29.2.2016

EU/1/11/693

Rivastigmine Actavis

Iceland

15.3.2016

EU/1/11/694

Nulojix

Liechtenstein

29.2.2016

EU/1/11/694

Nulojix

Norway

26.2.2016

EU/1/11/694

Nulojix

Iceland

17.3.2016

EU/1/11/695

Leganto

Liechtenstein

29.2.2016

EU/1/11/695

Leganto

Norway

1.2.2016

EU/1/11/695

Leganto

Iceland

26.1.2016

EU/1/11/696

Bydureon

Liechtenstein

29.2.2016

EU/1/11/696

Bydureon

Norway

10.3.2016

EU/1/11/696

Bydureon

Iceland

17.3.2016

EU/1/11/697

Temozolomide SUN

Liechtenstein

30.4.2016

EU/1/11/697

Temozolomide SUN

Norway

29.4.2016

EU/1/11/697

Temozolomide SUN

Iceland

18.5.2016

EU/1/11/698

Yervoy

Liechtenstein

30.4.2016

EU/1/11/698

Yervoy

Norway

29.4.2016

EU/1/11/698

Yervoy

Iceland

18.5.2016

EU/1/11/699

Fampyra

Liechtenstein

30.6.2016

EU/1/11/699

Fampyra

Iceland

15.6.2016

EU/1/11/700

Benlysta

Liechtenstein

29.2.2016

EU/1/11/700

Benlysta

Norway

26.2.2016

EU/1/11/700

Benlysta

Iceland

18.3.2016

EU/1/11/702

Levetiracetam ratiopharm

Liechtenstein

30.4.2016

EU/1/11/702

Levetiracetam ratiopharm

Norway

18.5.2016

EU/1/11/702

Levetiracetam ratiopharm

Iceland

19.5.2016

EU/1/11/703

Xgeva

Liechtenstein

30.6.2016

EU/1/11/703

Xgeva

Norway

18.5.2016

EU/1/11/703

Xgeva

Iceland

13.5.2016

EU/1/11/704

Victrelis

Liechtenstein

29.2.2016

EU/1/11/704

Victrelis

Iceland

17.3.2016

EU/1/11/704

Victrelis

Norway

3.3.2016

EU/1/11/705

Vibativ

Liechtenstein

30.6.2016

EU/1/11/705

Vibativ

Iceland

13.6.2016

EU/1/11/705

Vibativ

Norway

9.6.2016

EU/1/11/706

Levodopa/Carbidopa/Entacapone Orion

Liechtenstein

30.6.2016

EU/1/11/706

Levodopa/Carbidopa/Entacapone Orion

Iceland

15.6.2016

EU/1/11/707

Trajenta

Liechtenstein

30.4.2016

EU/1/11/707

Trajenta

Norway

19.4.2016

EU/1/11/707

Trajenta

Iceland

31.3.2016

EU/1/11/708

Entacapone Orion

Liechtenstein

30.4.2016

EU/1/11/708

Entacapone Orion

Norway

21.4.2016

EU/1/11/708

Entacapone Orion

Iceland

26.4.2016

EU/1/11/709

Buccolam

Liechtenstein

30.6.2016

EU/1/11/709

Buccolam

Norway

24.6.2016

EU/1/11/709

Buccolam

Iceland

13.6.2016

EU/1/11/714

Zytiga

Liechtenstein

30.6.2016

EU/1/11/714

Zytiga

Norway

14.6.2016

EU/1/11/714

Zytiga

Iceland

13.6.2016

EU/1/11/718

Dexdor

Liechtenstein

30.6.2016

EU/1/11/718

Dexdor

Norway

20.6.2016

EU/1/11/718

Dexdor

Iceland

13.6.2016

EU/1/11/719

Telmisartan Teva Pharma

Liechtenstein

30.6.2016

EU/1/11/719

Telmisartan Teva Pharma

Norway

23.6.2016

EU/1/11/749

Caprelsa

Norway

14.1.2016

EU/1/11/749

Caprelsa

Iceland

14.1.2016

EU/1/12/764

Pixuvri

Liechtenstein

30.4.2016

EU/1/12/764

Pixuvri

Norway

1.4.2016

EU/1/12/764

Pixuvri

Iceland

31.3.2016

EU/1/13/818

Bosulif

Norway

14.1.2016

EU/1/13/818

Bosulif

Iceland

13.1.2016

EU/1/13/848

Erivedge

Norway

16.6.2016

EU/1/13/848

Erivedge

Iceland

15.6.2016

EU/1/13/875

Deltyba

Norway

29.3.2016

EU/1/13/875

Deltyba

Iceland

22.3.2016

EU/1/13/890

Cometriq

Liechtenstein

29.2.2016

EU/1/13/890

Cometriq

Norway

20.1.2016

EU/1/13/890

Cometriq

Iceland

19.1.2016

EU/1/13/901

Sirturo

Liechtenstein

29.2.2016

EU/1/13/901

Sirturo

Norway

14.1.2016

EU/1/13/901

Sirturo

Iceland

13.1.2016

EU/1/14/987

Holoclar

Iceland

4.1.2016

EU/1/15/999

Zykadia

Liechtenstein

30.4.2016

EU/1/15/999

Zykadia

Norway

6.4.2016

EU/1/15/999

Zykadia

Iceland

31.3.2016

EU/2/06/061

Nobilis Influenza H5N2

Norway

28.6.2016

EU/2/10/107

Veraflox

Liechtenstein

29.2.2016

EU/2/10/107

Veraflox

Norway

13.1.2016

EU/2/10/107

Veraflox

Iceland

15.1.2016

EU/2/10/115

Comfortis

Liechtenstein

29.2.2016

EU/2/10/115

Comfortis

Norway

18.1.2016

EU/2/10/115

Comfortis

Iceland

15.1.2016

EU/2/10/116

Melosus

Liechtenstein

29.2.2016

EU/2/10/116

Melosus

Norway

22.1.2016

EU/2/10/116

Melosus

Iceland

22.1.2016

EU/2/10/118

Activyl

Liechtenstein

29.2.2016

EU/2/10/118

Activyl

Norway

29.1.2016

EU/2/10/118

Activyl

Iceland

15.1.2016

EU/2/10/119

Cimalgex

Liechtenstein

29.2.2016

EU/2/10/119

Cimalgex

Norway

19.1.2016

EU/2/10/119

Cimalgex

Iceland

15.1.2016

EU/2/11/120

Zulvac 1 + 8 Ovis

Liechtenstein

29.2.2016

EU/2/11/120

Zulvac 1 + 8 Ovis

Norway

19.1.2016

EU/2/11/120

Zulvac 1 + 8 Ovis

Iceland

15.1.2016

EU/2/11/121

CaniLeish

Liechtenstein

29.2.2016

EU/2/11/121

CaniLeish

Norway

18.1.2016

EU/2/11/121

CaniLeish

Iceland

15.1.2016

EU/2/11/122

Bluevac BTV8

Liechtenstein

30.4.2016

EU/2/11/122

Bluevac BTV8

Norway

29.3.2016

EU/2/11/122

Bluevac BTV8

Iceland

29.3.2016

EU/2/11/123

Procox

Liechtenstein

29.2.2016

EU/2/11/123

Procox

Norway

20.1.2016

EU/2/11/123

Procox

Iceland

20.1.2016

EU/2/11/124

Zuprevo

Liechtenstein

30.6.2016

EU/2/11/124

Zuprevo

Norway

1.6.2016

EU/2/11/124

Zuprevo

Iceland

26.5.2016

EU/2/11/125

Certifect

Liechtenstein

30.4.2016

EU/2/11/125

Certifect

Norway

4.5.2016

EU/2/11/125

Certifect

Iceland

12.5.2016

EU/2/11/126

MS-H Impfstoff

Liechtenstein

30.6.2016

EU/2/11/126

MS-H Vaccine

Iceland

23.5.2016

EU/2/11/126

MS-H-Vaksine

Norway

24.5.2016

EU/2/11/128

Emdocam

Liechtenstein

30.6.2016

EU/2/11/128

Emdocam

Norway

27.6.2016

EU/2/11/129

Proteq West Nile

Liechtenstein

30.6.2016

EU/2/11/129

Proteq West Nile

Norway

24.5.2016

EU/2/11/129

Proteq West Nile

Iceland

23.5.2016

EU/2/11/130

Zulvac 1 Bovis

Liechtenstein

30.4.2016

EU/2/11/130

Zulvac 1 Bovis

Norway

2.5.2016

EU/2/11/130

Zulvac 1 Bovis

Iceland

13.5.2016

EU/2/11/131

Zulvac 1 Ovis

Liechtenstein

30.4.2016

EU/2/11/131

Zulvac 1 Ovis

Norway

2.5.2016

EU/2/11/131

Zulvac 1 Ovis

Iceland

13.5.2016

---

ANNEX III

List of extended marketing authorisations

The following marketing authorisations have been extended in the EEA EFTA States during the period 1 January-30 June 2016:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/03/262/011 | Emend | Norway | 15.1.2016 |
| EU/1/03/262/011 | Emend | Iceland | 14.1.2016 |
| EU/1/06/356/011-019 | Exjade | Norway | 1.4.2016 |
| EU/1/06/356/011-019 | Exjade | Iceland | 31.3.2016 |
| EU/1/10/612/010-013 | Revolade | Norway | 14.4.2016 |
| EU/1/10/612/010-013 | Revolade | Iceland | 26.4.2016 |
| EU/1/10/655/007-011 | Brilique | Norway | 26.2.2016 |
| EU/1/10/655/007-011 | Brilique | Iceland | 18.3.2016 |
| EU/1/13/851/004-006 | Lojuxta | Norway | 1.3.2016 |
| EU/1/13/851/004-006 | Lojuxta | Iceland | 18.3.2016 |
| EU/1/14/971/007-010 | Trevicta | Norway | 7.6.2016 |
| EU/1/14/971/007-010 | Trevicta | Iceland | 15.6.2016 |
| EU/1/98/067/004 | Mabthera | Iceland | 15.6.2016 |
| EU/1/98/067/004 | Mabthera | Norway | 26.5.2016 |
| EU/2/13/158/016-031 | Bravecto | Norway | 7.6.2016 |
| EU/2/13/158/016-031 | Bravecto | Iceland | 25.5.2016 |

EU-Number

Product

Country

Date of authorisation

EU/1/03/262/011

Emend

Norway

15.1.2016

EU/1/03/262/011

Emend

Iceland

14.1.2016

EU/1/06/356/011-019

Exjade

Norway

1.4.2016

EU/1/06/356/011-019

Exjade

Iceland

31.3.2016

EU/1/10/612/010-013

Revolade

Norway

14.4.2016

EU/1/10/612/010-013

Revolade

Iceland

26.4.2016

EU/1/10/655/007-011

Brilique

Norway

26.2.2016

EU/1/10/655/007-011

Brilique

Iceland

18.3.2016

EU/1/13/851/004-006

Lojuxta

Norway

1.3.2016

EU/1/13/851/004-006

Lojuxta

Iceland

18.3.2016

EU/1/14/971/007-010

Trevicta

Norway

7.6.2016

EU/1/14/971/007-010

Trevicta

Iceland

15.6.2016

EU/1/98/067/004

Mabthera

Iceland

15.6.2016

EU/1/98/067/004

Mabthera

Norway

26.5.2016

EU/2/13/158/016-031

Bravecto

Norway

7.6.2016

EU/2/13/158/016-031

Bravecto

Iceland

25.5.2016

---

ANNEX IV

List of withdrawn marketing authorisations

The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 January-30 June 2016:

| EU-Number | Product | Country | Date of withdrawal |
| --- | --- | --- | --- |
| EU/1/01/179 | Osigraft | Norway | 18.1.2016 |
| EU/1/01/179 | Osigraft | Iceland | 4.1.2016 |
| EU/1/05/314 | Kepivance | Liechtenstein | 30.4.2016 |
| EU/1/05/314 | Kepivance | Iceland | 29.3.2016 |
| EU/1/05/314 | Kepivance | Norway | 22.3.2016 |
| EU/1/13/831 | Capecitabin SUN | Liechtenstein | 30.6.2016 |
| EU/1/13/833 | Nuedexta | Liechtenstein | 30.4.2016 |
| EU/1/13/833 | Nuedexta | Norway | 31.3.2016 |
| EU/1/13/833 | Nuedexta | Iceland | 21.3.2016 |
| EU/1/14/942 | Clopidogrel/Acetylsalicylic acid Teva | Norway | 15.6.2016 |
| EU/2/12/138 | RevitaCAM | Liechtenstein | 30.6.2016 |
| EU/2/12/138 | RevitaCAM | Norway | 15.6.2016 |
| EU/2/12/138 | RevitaCAM | Iceland | 13.6.2016 |

EU-Number

Product

Country

Date of withdrawal

EU/1/01/179

Osigraft

Norway

18.1.2016

EU/1/01/179

Osigraft

Iceland

4.1.2016

EU/1/05/314

Kepivance

Liechtenstein

30.4.2016

EU/1/05/314

Kepivance

Iceland

29.3.2016

EU/1/05/314

Kepivance

Norway

22.3.2016

EU/1/13/831

Capecitabin SUN

Liechtenstein

30.6.2016

EU/1/13/833

Nuedexta

Liechtenstein

30.4.2016

EU/1/13/833

Nuedexta

Norway

31.3.2016

EU/1/13/833

Nuedexta

Iceland

21.3.2016

EU/1/14/942

Clopidogrel/Acetylsalicylic acid Teva

Norway

15.6.2016

EU/2/12/138

RevitaCAM

Liechtenstein

30.6.2016

EU/2/12/138

RevitaCAM

Norway

15.6.2016

EU/2/12/138

RevitaCAM

Iceland

13.6.2016

---

ANNEX V

List of suspended marketing authorisations

The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 January-30 June 2016:

| EU-Number | Product | Country | Date of suspension |
| --- | --- | --- | --- |
| | | | |
| | | | |
| | | | |

EU-Number

Product

Country

Date of suspension

---